Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
20 participants
INTERVENTIONAL
2010-11-30
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to determine and compare satiety ratings, changes in food intake, and gastrointestinal effects for four fibers: fructooligosaccharide, inulin, soluble corn fiber, and resistant starch.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Satiety Response of Short Chain Fructooligosaccharide
NCT01100788
Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers
NCT00958399
Resistant Starch and Satiety
NCT01187875
Assessing Fermentability of a Dietary Fiber
NCT01497249
The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption
NCT05743790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low fiber control
no treatment dinner bar, no treatment breakfast bar
Control
Dinner bar fortified with 0g fiber; breakfast bar fortified with 0g dietary fiber.
Promitor soluble corn fiber
12g in dinner bar, 11g in breakfast bar
Soluble corn fiber
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
FiberSym resistant starch
12g in dinner bar, 11g breakfast bar
Resistant starch
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Orafti P95 fructooligosaccharide
12g in dinner bar, 11g in breakfast bar
Fructooligosaccharide
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Orafti HPX inulin
12g in dinner bar, 11g in breakfast bar
Inulin
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
Dinner bar fortified with 0g fiber; breakfast bar fortified with 0g dietary fiber.
Soluble corn fiber
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Resistant starch
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Fructooligosaccharide
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Inulin
Dinner bar fortified with 12g fiber; breakfast bar fortified with 11g dietary fiber.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-40 years
* Nonsmoking
* Not taking weight loss medications
* Non-dieting (weight has not changed more than 11 pounds over three months)
* BMI between 18.5 and 29
* Spoken and written English literacy
Exclusion Criteria
* Food allergies to wheat, soy, peanut, or dairy
* BMI less than 25 or greater than 29 upon admission to study
* Cancer diagnosis in past 5 years
* History of heart disease, kidney disease, diabetes, or eating disorder
* History of ulcerative colitis, Crohn's disease, or any other gastrointestinal condition
* History of drug or alcohol abuse in past 6 months
* Use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication
* Concurrent or recent (within 30 days) intervention study participation
* Pregnant or lactating
* Irregular menstrual cycle
* Vegetarians
* People who eat more than approximately 15 grams of fiber per day
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne L Slavin, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1003E78714
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.